|4Jun 8, 7:09 PM ET

HALKUFF DAWN 4

4 · XERIS PHARMACEUTICALS INC · Filed Jun 8, 2021

Insider Transaction Report

Form 4
Period: 2021-06-08
HALKUFF DAWN
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-08+11,22811,228 total
    Exercise: $3.90Exp: 2031-06-08Common Stock (11,228 underlying)
Footnotes (1)
  • [F1]Such options will vest in full upon the earlier to occur of June 8, 2022 or the date of the Company's next annual meeting of stockholders.

Documents

1 file
  • 4
    wf-form4_162319374400964.xmlPrimary

    FORM 4